# Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

> **NCT07692607** · NA · COMPLETED · sponsor: **LucasBio** · enrollment: 25 (actual)

## Conditions studied

- Autologous Hematopoietic Stem Cell Transplant

## Interventions

- **BIOLOGICAL:** CIK cells

## Key facts

- **NCT ID:** NCT07692607
- **Lead sponsor:** LucasBio
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-28
- **Primary completion:** 2025-02-11
- **Final completion:** 2026-03-17
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692607, "Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*